Spots Global Cancer Trial Database for blood stem cell transplantation
Every month we try and update this database with for blood stem cell transplantation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Exercise During the Allogeneic Stem Cell Transplantation | NCT00883714 | Fatigue Allogeneic Stem... | Supervised exer... Exercise Instru... | 18 Years - 70 Years | Charite University, Berlin, Germany | |
Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin | NCT00822770 | Stem Cell Trans... Leukemia | Plerixafor Filgrastim Fludarabine Busulfan Allogeneic bloo... ATG (Thymoglobu... | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin | NCT00822770 | Stem Cell Trans... Leukemia | Plerixafor Filgrastim Fludarabine Busulfan Allogeneic bloo... ATG (Thymoglobu... | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
Bortezomib Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease (GVHD) After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell Transplantation | NCT00369226 | Hematologic Mal... | Bortezomib (Vel... Tacrolimus Methotrexate blood stem cell... | 18 Years - | Dana-Farber Cancer Institute | |
GM-CSF Vaccinations After Allogeneic Blood Stem Cell Transplantation in Patients With Advanced Myeloid Malignancies | NCT00426205 | Myelodysplastic... Refractory Acut... Refractory CML ... | GM-CSF secretin... | 18 Years - | Dana-Farber Cancer Institute | |
GM-CSF Vaccinations After Allogeneic Blood Stem Cell Transplantation in Patients With Advanced Myeloid Malignancies | NCT00426205 | Myelodysplastic... Refractory Acut... Refractory CML ... | GM-CSF secretin... | 18 Years - | Dana-Farber Cancer Institute | |
Exercise During the Allogeneic Stem Cell Transplantation | NCT00883714 | Fatigue Allogeneic Stem... | Supervised exer... Exercise Instru... | 18 Years - 70 Years | Charite University, Berlin, Germany |